<?xml version="1.0" ?>
<akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <act name="section">
    <meta>
      <identification source="#publicresource">
        <FRBRWork>
          <FRBRthis value="/us-ky/act/krs/217.911"/>
          <FRBRuri value="/us-ky/act/krs/217.911"/>
          <FRBRdate date="2025-12-31" name="enacted"/>
          <FRBRauthor href="#ky-legislature"/>
          <FRBRcountry value="us-ky"/>
        </FRBRWork>
        <FRBRExpression>
          <FRBRthis value="/us-ky/act/krs/217.911/eng"/>
          <FRBRuri value="/us-ky/act/krs/217.911/eng"/>
          <FRBRdate date="2025-12-31" name="publication"/>
          <FRBRauthor href="#publicresource"/>
          <FRBRlanguage language="eng"/>
        </FRBRExpression>
        <FRBRManifestation>
          <FRBRthis value="/us-ky/act/krs/217.911/eng/akn"/>
          <FRBRuri value="/us-ky/act/krs/217.911/eng/akn"/>
          <FRBRdate date="2025-12-31" name="generation"/>
          <FRBRauthor href="#cosilico"/>
        </FRBRManifestation>
      </identification>
      <references source="#cosilico">
        <TLCOrganization eId="ky-legislature" href="/ontology/organization/us-ky/legislature" showAs="Kentucky General Assembly"/>
        <TLCOrganization eId="publicresource" href="https://public.resource.org" showAs="Public.Resource.Org"/>
        <TLCOrganization eId="cosilico" href="https://cosilico.ai" showAs="Cosilico"/>
      </references>
    </meta>
    <body>
      <section eId="sec_217_911">
        <num>217.911</num>
        <content>
          <p>The board may exempt a particular drug product from the requirements of , upon application of a manufacturer or distributor showing that the drug productâ€™s size, texture, or other unique characteristics render imprinting impractical or impossible.</p>
        </content>
      </section>
    </body>
  </act>
</akomaNtoso>
